Lena Sabih, MD
Rheumatology · North Kansas City, MONPI 1588194211
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.7% of the total across 230 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 24 manufacturers reported payments, led by Amgen at 26.1% of the total.
Across 230 payments — averaging $18.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$1K
- AbbVie$1K
- Johnson & Johnson$480
- AstraZeneca$289
- Lilly USA, LLC$200
- UCB, Inc.$188
- plus $970 from 18 others
What the payments were for
- Food & beverage$4,19197%
- Education$1433%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 81 | $1,133 |
| AbbVie | 66 | $1,075 |
| Johnson & Johnson | 20 | $480 |
| AstraZeneca(2 entities) | 6 | $289 |
| Lilly USA, LLC | 13 | $200 |
| UCB, Inc. | 6 | $188 |
| Kiniksa Pharmaceuticals International, PLC | 4 | $170 |
| GSK | 5 | $107 |
| Janssen Scientific Affairs, LLC | 1 | $105 |
| Pfizer | 5 | $92 |
| E.r. Squibb & Sons, L.L.C. | 4 | $80 |
| ANI Pharmaceuticals, Inc. | 2 | $76 |
| Boehringer Ingelheim | 3 | $58 |
| Astellas Pharma US Inc | 2 | $53 |
| Novartis | 3 | $53 |
| Edwards Lifesciences | 1 | $36 |
| Phathom Pharmaceuticals, Inc. | 1 | $27 |
| Abbott | 1 | $20 |
| Lundbeck LLC | 1 | $20 |
| Fresenius Kabi USA, LLC | 1 | $19 |
| Fidia Pharma USA Inc. | 1 | $16 |
| Averitas Pharma Inc. | 1 | $15 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $15 |
| Organon | 1 | $5 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,334 in reported general payments places this provider in the 65th percentile of 134 rheumatology providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Enbrel SureclickEtanercept | 36 | $284,481 |
| Humira(Cf) PenAdalimumab | 17 | $111,918 |
| Hydroxychloroquine Sulfate | 269 | $7,494 |
| MethotrexateMethotrexate Sodium | 133 | $3,023 |
| Celecoxib | 117 | $2,384 |
| Mycophenolate Mofetil | 18 | $2,321 |
| Leflunomide | 29 | $1,386 |
| Prednisone | 272 | $1,145 |
| Colchicine | 19 | $876 |
| Duloxetine Hcl | 73 | $870 |
| Tizanidine Hcl | 18 | $835 |
| Azathioprine | 11 | $794 |
| Naproxen | 62 | $432 |
| Allopurinol | 30 | $375 |
| Gabapentin | 29 | $352 |
Paid to pharmacies, not to this prescriber.
Other rheumatology in North Kansas City
- Anne WinklerCarthage$1.6M
- Adam KilianSaint Louis$565K
- Alfred KimSaint Louis$486K
- Mark BoxKansas City$304K
- Sona KamatSaint Louis$268K
- Robert JacksonMemphis$152K
- Richard BrasingtonSaint Louis$100K
- Michael JosephJoplin$94K
- Ghaith NoaisehKansas City$69K
- Thomas ScottKansas City$48K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.